Tuesday, February 21, 2017 8:09:45 AM
EYEG - 1.6399 Pre-market now at 2.30/2.35
Valeant Pharmaceuticals, EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product; Upfront Payment For EyeGate Not Disclosed In PR, Has Potential To Receive Milestone Payments Based Off Of Sales And Development Milestones
Valeant Pharmaceuticals, EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product; Upfront Payment For EyeGate Not Disclosed In PR, Has Potential To Receive Milestone Payments Based Off Of Sales And Development Milestones
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
